Gavriilidis Paschalis, O'Callaghan John Matthew, Hunter James, Fernando Tyrrel, Imray Christopher, Roy Deb
Department of Vascular Access and Renal Transplantation, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
Transpl Int. 2021 Aug;34(8):1374-1385. doi: 10.1111/tri.13901. Epub 2021 Jul 6.
There is limited evidence regarding the impact of allograft nephrectomy (AN) on the long-term outcome of subsequent kidney re-transplantation compared with no prior allograft nephrectomy. The aim of the present study was to conduct a systematic review and meta-analysis to estimate the accumulation of evidence over time. Primary outcomes were 5-year graft and patient survival. Cochrane library, Google scholar, PubMed, Medline and Embase were systematically searched. Meta-analysis was conducted using both fixed- and random-effects models. Study quality was assessed in duplicate using the Newcastle-Ottawa scale. Sixteen studies were included, with a total of 2256 patients. All included studies were retrospective and comparative. There was no significant difference in 5-year graft survival (GS) [Hazard Ratio (HR) = 1.11, 95% Confidence Intervals (CI): 0.89, 1.38, P = 0.37, I = 10%) or in 5-year patient survival (PS; HR = 0.70, 95% CI: 0.45, 1.10, P = 0.12, I = 0%]. Patients in the AN cohort were significantly younger than patients in the nonallograft nephrectomy (NAN) cohort by one year. Prior allograft nephrectomy was associated with a significantly higher risk of delayed graft function (DGF), acute rejection, primary nonfunction (PNF), per cent of panel reactive antibodies (% PRA) and allograft loss of the subsequent transplant. Although, DGF, % PRA, acute rejection and primary nonfunction rates were significantly higher in the AN cohort, allograft nephrectomy prior to re-transplantation had no significant association with five-year graft and patient survival.
与未进行过同种异体肾切除术相比,关于同种异体肾切除术(AN)对后续肾脏再次移植长期结局影响的证据有限。本研究的目的是进行系统评价和荟萃分析,以估计随时间积累的证据。主要结局为5年移植物和患者生存率。系统检索了Cochrane图书馆、谷歌学术、PubMed、Medline和Embase。使用固定效应模型和随机效应模型进行荟萃分析。采用纽卡斯尔-渥太华量表对研究质量进行双人评估。纳入16项研究,共2256例患者。所有纳入研究均为回顾性比较研究。5年移植物生存率(GS)[风险比(HR)=1.11,95%置信区间(CI):0.89,1.38,P=0.37,I²=10%]或5年患者生存率(PS;HR=0.70,95%CI:0.45,1.10,P=0.12,I²=0%]无显著差异。AN队列中的患者比非同种异体肾切除术(NAN)队列中的患者年轻一岁。既往同种异体肾切除术与移植肾功能延迟(DGF)、急性排斥反应、原发性无功能(PNF)、群体反应性抗体百分比(%PRA)以及后续移植的同种异体移植物丢失风险显著升高相关。尽管AN队列中的DGF、%PRA、急性排斥反应和原发性无功能发生率显著更高,但再次移植前的同种异体肾切除术与5年移植物和患者生存率无显著关联。